Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Excessive olivo‐cerebellar synchrony is implicated in essential tremor. Because synchrony in some networks is mediated by gap junctions, we examined whether the gap junction blockers heptanol, octanol, carbenoxolone, and mefloquine suppress tremor in the mouse harmaline model, and performed an open‐treatment clinical study of mefloquine for essential tremor. Digitized motion was used to quantify tremor in mice administered harmaline, 20 mg/kg s.c. In mice the broad‐spectrum gap junction blockers heptanol, octanol (350 mg/kg i.p. each), and carbenoxolone (20 mg/kg) suppressed harmaline tremor. Mefloquine (50 mg/kg), which blocks gap junctions containing connexin 36, robustly suppressed harmaline tremor. Glycyrrhizic acid (related to carbenoxolone) and chloroquine (related to mefloquine), which do not block gap junctions, failed to suppress harmaline tremor in mice. Clinically, tremor was assessed with standard rating scales, and subjects asked to take 62.5, 125, and 250 mg mefloquine weekly for 12 weeks at each dose. None of the four human subjects showed a meaningful tremor reduction with mefloquine, likely because clinical levels were below those required for efficacy. In view of recent genetic evidence, the anti‐tremor mechanism of these compounds is uncertain but may represent a novel therapeutic target, possibly involving gap junctions other than those containing connexin 36. © 2006 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gait disorder of advanced essential tremor
Stolze, H. (2001) · Brain · doi:10.1093/brain/124.11.2278 · Cited by 275
Reanalysis of P2X7Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J. (1996) · Movement Disorders · doi:10.1002/mds.870110306 · Cited by 235
Teubner, B., Degen, J., Söhl, G., Güldenagel, M., Bukauskas, F. F., Trexler, E. B., Verselis, V. K., De Zeeuw, C. I., Lee, C. G., Kozak, C. A., et al. (2000) · The Journal of Membrane Biology · doi:10.1007/s00232001094 · Cited by 216
The effect of alcohol on essential tremor
GROWDON, J. H., SHAHANI, B. T., & YOUNG, R. R. (1975) · Neurology · doi:10.1212/wnl.25.3.259 · Cited by 147
Cited by
Juszczak, G. R., & Swiergiel, A. H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.014 · Cited by 211
“Such a control compound for CBX can be glycyrrhizic acid (Martin and Handforth, 2006), structurally similar and sharing some properties with CBX (Gomez-Sanchez and Gomez-Sanchez, 1992; Hanafusa et al., 2002; Zhang et al., 2006), but not affecting gap junction communication at concentrations below…”
BackgroundInfluentialSchoenfeld, T. J., Kloth, A. D., Hsueh, B., Runkle, M. B., Kane, G. A., Wang, S. S.-H., & Gould, E. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3234-13.2014 · Cited by 49
“Control mice were treated with the vehicle (veh) or with chloroquine (CQ) and glycyrrhizic acid (GA), which lack the gap junction-blocking capabilities of MQ and CBX but are structurally similar (Martin and Handforth, 2006).”
BackgroundMethodEmerging strategies in the management of essential tremor
Hedera, P. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616679123 · Cited by 36
(2011) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52014-2.00033-1 · Cited by 27
Metadata
- Authors
- Martin, F. C., & Handforth, A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2006-06-13
- Volume
- 21
- Issue
- 10
- Pages
- 1641-1649
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2027254482
- Cited by
- 79
- References
- 5
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. https://app.cochat.ai/papers/10.1002/mds.20940
- The paper
- Martin, F. C., & Handforth, A. (2006). Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. Movement Disorders. https://doi.org/10.1002/mds.20940
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.